OncoPLEX Plus Myrosinase 30 C

OncoPLEX™ Plus Myrosinase supports glucoraphanin conversion, phase II detoxification enzyme activity, antioxidant defenses, and healthy cell-life cycles. Its panel combines 30 mg of glucoraphanin from broccoli seed extract with 170 mg of mustard-seed myrosinase, providing enzyme activity measured at 17 U. Xymogen explains that myrosinase promotes conversion of naturally occurring glucoraphanin into sulforaphane, a biologically active compound associated with cruciferous vegetables. The 100 mg vitamin C contribution functions as a cofactor in Xymogen’s explanation of that enzyme. The reference sheet identifies a 4:1 ratio between precursor and myrosinase and describes enhanced sulforaphane bioavailability when both accompany each other. These benefits remain within the product’s stated structure/function roles: antioxidant activity, cellular health, and ordinary detoxification pathways.

OncoPLEX™ Plus Myrosinase is intended for adults seeking a concentrated broccoli-derived glucoraphanin source paired with the plant enzyme needed for its conversion. It may suit a practitioner-directed plan focused on antioxidant-system activity, Nrf2-related phase II enzyme production, or nutritional support for normal cell-life regulation. Per capsule, glucoraphanin contributes 30 mg, vitamin C contributes 100 mg, and mustard-derived myrosinase contributes 170 mg. People sensitive to broccoli, mustard, ascorbic acid, hypromellose, microcrystalline cellulose, ascorbyl palmitate, or silica should examine the panel before use. Xymogen’s exclusion statement covers gluten, wheat, soy, yeast, egg, sesame, peanuts, tree nuts, fish, shellfish, genetically modified ingredients, animal and dairy materials, artificial colors, sweeteners, and preservatives.

OncoPLEX™ Plus Myrosinase has no manufacturer list of expected adverse effects, but its broccoli and mustard sources still warrant individual review. Xymogen states: Consult your healthcare professional before use. Individuals taking medication should discuss potential interactions with their healthcare professional. Anyone with sensitivity to Brassica oleracea italica, Sinapis alba, vitamin C, or any capsule material should evaluate that composition before beginning. Glucoraphanin appears at 30 mg on the active panel; the 170 mg myrosinase entry is measured at 17 U. Silica and ascorbyl palmitate join microcrystalline cellulose, water, and hypromellose among inactive materials. Keep the container securely closed under cool, dry conditions and outside children’s reach. An unexpected reaction calls for discontinuing the capsule and seeking prompt guidance from the professional overseeing the regimen.

OncoPLEX™ Plus Myrosinase supports overall health by pairing a cruciferous-vegetable precursor with its conversion enzyme. Glucoraphanin comes from broccoli seed extract, while myrosinase is supplied by mustard powder. Xymogen explains that this plant enzyme converts glucoraphanin into sulforaphane, which activates antioxidant activity and phase II detoxification enzyme production through pathways that include KEAP1, Nrf2, and ARE signaling. The manufacturer also discusses healthy redox cycling and cell-life regulation within that mechanism. Vitamin C contributes 100 mg and is included as a cofactor for myrosinase activity. The finished capsule uses a 4:1 glucoraphanin-to-myrosinase ratio rather than relying solely on variable gastrointestinal conversion. That combination supplies a defined precursor, an enzyme measured at 17 U, and a vitamin cofactor for Xymogen’s stated antioxidant and detoxification applications.